Figure 1From: High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vaginaPre-RT MRI image (T1 with contrast) showing large vaginal cancer with extension to pelvic side wall and peri-urethral region. Interstitial implantation showing coverage of clinical tumor volume (red) with isodose lines (100%-red, 90%-blue, 75%-yellow, and 50% – green).Back to article page